we care from the heart
  • Welcome to the most comprehensive medical lab in Egypt!

    al mokhtabar is the largest private medical laboratory testing company in the Middle East, providing diagnostic laboratory services, pathological and clinical tests for medical communities in Egypt. The company offers a portfolio of over than 1,200 clinical analysis in the areas of immunology, hematology/coagulation, clinical chemistry, parasitology, microbiology/infectious diseases, toxicology, cytology, surgical pathology, flowcytometry, molecular biology and cytogenetics.

    Read More!

  • Stay informed!

    We are constantly refining our portfolio in terms of units & medical tests. Check out this section and learn about all the new medical tests that we add to our vast array of 1200 tests!

    Read more!

  • Because we care from the heart!

    Every business has to abide by certain quality measures and standards to ensure the best service. In no field is this more applicable than in the medical field! At the end of the day, we deal with health, the corner stone of everyone’s life. Because we believe this and take it to heart, we are constantly striving to improve our quality control measures on all fronts.

    Read More!

Physician Services


Molecular Biology

Molecular Biology Unit

Our Staff

The Molecular Biology Unit is an fundamental l part of al mokhtabar medical laboratories and as such, employs the some of the most highly qualified staff in Egypt.

Our molecular biology unit is headed by Dr Mahmoud Ahmed Ali, M.D.

The unit also employs a unit head designee, WHO HAS with PHD’s in Molecular Genetics.

In addition to our medical team, we also use the experience of 5 well trained chemists, with experience in the Molecular Biology field.

Our Equipment

Every Molecular Biology unit needs the input of a professional staff and the support of the right equipment for the best output (Link to instruments).

Our Services

We offer a wide array of specialized services including:

  1. Qualitative detection of HCV RNA, Cytomegalo virus & mycobacterium tuberculosis by PCR.

  2. Quantitative detection of HCV.

  3. Qualitative detection of HBV by PCR.

  4. Human Leukocyte Antigen (HLA) class I & class II typing by PCR followed by reverse hybridization (DYNAL SSO typing Kit).

  5. Qualitative detection of HIV and EBV.

  6. HCV Genotyping using INNO LiPA assay version 2.0, where testing of HCV genotypes (1-6) along with their subtypes were available.

  7. Testing for Factor V, MTHFR, PTH gene mutations.

  8. Testing for gene mutations including: Cardiovascular Disease (CVD), Familial Mediterranean Fever (FMF), β –Thalassemia, Fragile X syndrome, Duchenne muscular dystrophy (DMD) and Janus kinase 2 (JAK2) gene mutations.

  9. H1N1 testing.

Our Quality Control & Safety Measures

The successful application of PCR requires the proper use of techniques and interpretation of results. The advantages of these techniques can be offset by the demanding assay protocols and the need to follow quality assurance/quality control (QA/QC) procedures carefully.

PCR generates large numbers of amplicons; it therefore carries a high risk of contamination which in turn may lead to false results.

Laboratory Design

As such, our laboratory is designed and operated in a way that prevents contamination of reactions with amplified products from previous assays (carryover) and cross-contamination between samples to avoid false-positive results. Sample processing is divided into three physically separate rooms:

  • Sample Preparation Room (Pre-PCR)

  • Amplification Room                    (PCR)

  • Product Detection Room    (Post PCR)

PCR assays include positive and negative QC samples in addition to specific standards and calibrators on a routine basis.

Controls are run with each PCR batch at the same time, and by the same personnel who is in charge with testing patient samples.

Guidance and acceptability limits on quality control samples are documented in the laboratory’s SOP of each test along with the appropriate corrective actions for positive and negative control failures.

 Special care & vigilance are applied in fulfilling the CAP guidelines

Proficiency Testing

Providing the best patient care requires striving for the highest performance. As such, and in order to assess the laboratory ability to perform a particular method, the laboratory is participating in CAP (College of American Pathologists) proficiency testing (PR) program reflecting the specialty of the laboratory and level of expertise.

CAP proficiency testing allows the laboratory to regularly evaluate its performance and improve the accuracy of the patient results it provides.

Through this program, the CAP provides the laboratory with unknown specimens for testing. Samples are processed with the laboratory’s regular workload, using the same primary methods as the laboratory routinely analyzes patients' samples.

Results are returned to the CAP for evaluation using comparable peer groups with the most relevant instrument/reagent combinations to accurately assess our performance. In turn, the laboratory receives a report of its performance as well as a report summarizing the results of all participating laboratories.

The Molecular Biology unit results in CAP PT during the last three years were accurate and accepted.

If PT programs or samples are unavailable for a particular assay, the laboratory implements, at least semiannually, other procedures to test for internal consistency in the results, such as testing duplicate or split samples (alternative assessment).

Another procedure is to send a duplicate or split sample to a different accredited laboratory for comparison with the laboratory’s results.

CAP Accreditation

In April 2010, the Molecular Biology unit at al mokhtabar was accredited by the CAP (College of American pathologists)